PTC Therapeutics PTCT Deferred Taxes
Deferred Taxes at other companies
Segments
By segment
See fullOther financials
Where this comes from
Reported directly by PTC Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:DeferredIncomeTaxExpenseBenefit.
The official record: PTC Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about PTC Therapeutics's deferred taxes.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is PTC Therapeutics's deferred taxes?
- PTC Therapeutics (PTCT) reported deferred taxes of -$10K in Q1 2026.
- How has PTC Therapeutics's deferred taxes changed year-over-year?
- PTC Therapeutics's deferred taxes decreased by 600.0% year-over-year, from $2K to -$10K.
- What is the long-term trend for PTC Therapeutics's deferred taxes?
- Over 3 years (2021 to 2024), PTC Therapeutics's deferred taxes has grown at a 429.3% compound annual growth rate (CAGR), from $377K to -$55.91M.
- What does deferred taxes mean?
- Non-cash deferred tax expense or benefit representing the change in deferred tax assets/liabilities during the period.